Apellis Pharmaceuticals, Inc.
Compstatin analogs for treatment of neuropathic pain
Last updated:
Abstract:
In some aspects, the present invention provides methods of treating a subject in need of treatment for neuropathic pain, the method comprising administering a compstatin analog to the subject. In some embodiments, the compstatin analog is administered parenterally, e.g., intravenously.
Status:
Grant
Type:
Utility
Filling date:
9 Jul 2018
Issue date:
30 Jun 2020